OAC
GILD icon

OMERS Administration Corp’s Gilead Sciences GILD Stock Holding History

OMERS Administration Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8M Sell
441,303
-721,759
-62% -$95.1M 0.33% 55
2026
Q1 		$162M Buy
1,163,062
+1,088,354
+1,457% +$152M 1.04% 23
2025
Q4 		$9.17M Sell
74,708
-8,700
-10% -$1.06M 0.07% 130
2025
Q3 		$9.26M Hold
83,408
– – 0.07% 122
2025
Q2 		$9.25M Sell
83,408
-900
-1% -$95.8K 0.07% 121
2025
Q1 		$9.45M Buy
84,308
+15,125
+22% +$1.56M 0.08% 114
2024
Q4 		$6.39M Sell
69,183
-733
-1% -$66K 0.06% 141
2024
Q3 		$5.86M Sell
69,916
-800
-1% -$61K 0.05% 148
2024
Q2 		$4.85M Buy
+70,716
New +$4.72M 0.05% 160
2019
Q4 		– Sell
-147,100
Closed -$9.32M – 379
2019
Q3 		$9.32M Buy
147,100
+30,700
+26% +$2.01M 0.09% 115
2019
Q2 		$7.97M Buy
116,400
+87,600
+304% +$5.76M 0.08% 116
2019
Q1 		$1.94M Buy
+28,800
New +$1.91M 0.02% 152
2018
Q4 		– Sell
-99,200
Closed -$7.66M – 235
2018
Q3 		$7.66M Buy
99,200
+13,200
+15% +$997K 0.07% 107
2018
Q2 		$6.09M Buy
86,000
+24,100
+39% +$1.7M 0.06% 136
2018
Q1 		$4.67M Sell
61,900
-4,100
-6% -$326K 0.05% 183
2017
Q4 		$4.73M Buy
66,000
+28,200
+75% +$2.14M 0.05% 177
2017
Q3 		$3.06M Buy
37,800
+14,500
+62% +$1.11M 0.03% 225
2017
Q2 		$1.65M Buy
+23,300
New +$1.55M 0.02% 246
2016
Q2 		– Sell
-71,900
Closed -$6.61M – 597
2016
Q1 		$6.61M Buy
71,900
+16,500
+30% +$1.49M 0.15% 108
2015
Q4 		$5.61M Buy
55,400
+47,800
+629% +$4.97M 0.14% 122
2015
Q3 		$746K Buy
+7,600
New +$844K 0.02% 270
2015
Q1 		– Sell
-20,000
Closed -$1.89M – 422
2014
Q4 		$1.89M Buy
20,000
+14,900
+292% +$1.54M 0.06% 179
2014
Q3 		$543K Buy
+5,100
New +$499K 0.02% 299
2014
Q1 		– Sell
-72,000
Closed -$5.41M – 381
2013
Q4 		$5.41M Sell
72,000
-2,900
-4% -$202K 0.2% 66
2013
Q3 		$4.71M Hold
74,900
– – 0.45% 63
2013
Q2 		$3.84M Buy
+74,900
New +$3.9M 0.36% 67

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OMERS Administration Corp's GILD Position: Q2 2026 in Review

OMERS Administration Corp reduced its Gilead Sciences (GILD) stake by 62% in Q2 2026, selling an estimated $95.1M and leaving 441,303 shares worth $55.8M. The position accounts for 0.33% of the portfolio, ranked #55.

OMERS Administration Corp first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $162M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • OMERS Administration Corp held 441,303 shares of Gilead Sciences worth $55.8M as of Q2 2026.
  • OMERS Administration Corp sold 721,759 Gilead Sciences shares in Q2 2026, an estimated $95.1M.
  • Gilead Sciences made up 0.33% of OMERS Administration Corp's portfolio in Q2 2026, its #55 holding.
  • OMERS Administration Corp first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
  • OMERS Administration Corp's Gilead Sciences position peaked at $162M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.